Zobrazeno 1 - 10
of 287
pro vyhledávání: '"Gregory M.M Videtic"'
Autor:
Christopher A. Lemmon, MD, Gregory M.M. Videtic, MDCM, Sudish Murthy, MD, PhD, Kevin L. Stephans, MD, Marc Shapiro, MD, Usman Ahmad, MD, Daniel Raymond, MD, Vamsidhar Velcheti, MD, Alejandro Bribriesco, MD, Xuefei Jia, MS, James Stevenson, MD, Nathan A. Pennell, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 7, Pp 100359- (2022)
Introduction: Evidence supports the addition of immunotherapy to definitive chemoradiation for unresectable stage IIIA NSCLC. Adding pembrolizumab to neoadjuvant chemoradiation in patients with resectable stage IIIA NSCLC requires study for safety an
Externí odkaz:
https://doaj.org/article/2df3fb1980a64a9dbb7d5c8fbcdb48a6
Autor:
Senthilkumar Gandhidasan, MD, Chandana A. Reddy, MS, Neil M. Woody, MD, Kevin L. Stephans, MD, Molly Freeman, CNP, Gregory M.M. Videtic, MDCM, FRCPC, FACR, FASTRO
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 3, Pp 444-449 (2020)
Purpose: To report on the use of outpatient anesthesia (OPA) facilitating delivery of stereotactic body radiation therapy (SBRT) in patients with severe cognitive impairments (CI) diagnosed with inoperable early stage lung cancer. Methods and Materia
Externí odkaz:
https://doaj.org/article/eb1ade75714e45ae94fa220138c290dc
Publikováno v:
JCO Oncology Practice. 19:239-249
Autor:
Charles B. Simone, Jeffrey Bradley, Aileen B. Chen, Megan E. Daly, Alexander V. Louie, Clifford G. Robinson, Gregory M.M. Videtic, George Rodrigues
Publikováno v:
Practical Radiation Oncology. 13:195-202
Autor:
Robert Rulach, FRCR, David Ball, MD, Kevin L.M. Chua, FRCR, Max Dahele, MBChB, PhD, Dirk De Ruysscher, PhD, Kevin Franks, FRCR, Daniel Gomez, MD, Matthias Guckenberger, MD, Gerard G. Hanna, PhD, Alexander V. Louie, MD, PhD, Drew Moghanaki, MD, MPH, David A. Palma, MD, PhD, Clive Peedell, FRCR, Ahmed Salem, PhD, Shankar Siva, PhD, Gregory M.M. Videtic, MDCM, FRCPC, FACR, FASTRO, Anthony J. Chalmers, PhD, Stephen Harrow, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 2, Pp 100653- (2021)
Purpose: Thoracic reirradiation for non-small cell lung cancer with curative intent is potentially associated with severe toxicity. There are limited prospective data on the best method to deliver this treatment. We sought to develop expert consensus
Externí odkaz:
https://doaj.org/article/8cf5918332a84759847d320c465b5b34
Autor:
Isabel Jackson, PhD, Curtiland Deville, Jr., MD, Jillian Tsai, MD, PhD, Sharad Goyal, MD, Kathleen M. Hintenlang, PhD, FASTRO, Gregory M.M. Videtic, MDCM, FASTRO, William Small, Jr., MD, FASTRO, Brad Hoppe, MD, Robert C. Miller, MD, MBA, FASTRO
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 5, Pp 791-792 (2020)
Externí odkaz:
https://doaj.org/article/665f5cae8def48329b131fb4e32ae0b6
Autor:
Therese MJ. Kang, Nicholas Hardcastle, Anurag K. Singh, Ben J. Slotman, Gregory M.M. Videtic, Kevin L. Stephans, Felipe Couñago, Alexander V. Louie, Matthias Guckenberger, Susan V. Harden, Nikki M. Plumridge, Shankar Siva
Publikováno v:
Kang, T M J, Hardcastle, N, Singh, A K, Slotman, B J, Videtic, G M M, Stephans, K L, Couñago, F, Louie, A V, Guckenberger, M, Harden, S V, Plumridge, N M & Siva, S 2022, ' Practical considerations of single-fraction stereotactic ablative radiotherapy to the lung ', Lung Cancer, vol. 170, pp. 185-193 . https://doi.org/10.1016/j.lungcan.2022.06.014
Stereotactic ablative radiotherapy (SABR) is a well-established treatment for patients with medically inoperable early-stage non-small cell lung cancer (NSCLC) and pulmonary oligometastases. The use of single-fraction SABR in this setting is supporte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dda91eaf1afdf9b39c557b7b49ead210
https://doi.org/10.5167/uzh-220951
https://doi.org/10.5167/uzh-220951
Autor:
Kevin L. Stephans, Sarah M.C. Sittenfeld, Gregory M.M. Videtic, Chandana A. Reddy, Aditya Juloori
Publikováno v:
Clinical Lung Cancer. 22:e360-e365
Introduction We sought to evaluate the safety and efficacy of stereotactic body radiation therapy (SBRT) as salvage treatment for local recurrence after prior surgical resection for non–small-cell lung cancer (NSCLC). Materials and Methods We surve
Publikováno v:
Clinical lung cancer. 23(7)
For early stage medically inoperable lung cancer treated with fractionated stereotactic body radiotherapy (SBRT), higher local failure is associated with squamous carcinoma (SqC) compared to adenocarcinoma (AC). This study explored whether histology
Autor:
Tianjun Ma, Chieh-Wen Liu, Saeed Ahmed, Naichang Yu, Peng Qi, Kevin L. Stephans, Gregory M.M. Videtic, Ping Xia
Publikováno v:
Medical dosimetry : official journal of the American Association of Medical Dosimetrists. 47(3)
For patients undergoing stereotactic body radiation therapy for lung cancer, their tumor positions may vary due to anatomical changes. This study is to investigate whether adaptive re-planning is necessary for patients with large tumor position displ